Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis.
Multiple candidate biomarkers for amyotrophic lateral sclerosis (ALS) have emerged across a range of platforms. Replication of results, however, has been absent in all but a few cases, and the range of control samples has been limited. If progress toward clinical translation is to continue, the spec...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
John Wiley and Sons Inc.
2015
|